Inventor · disambiguated record
Amit Novik
Also filed as: NOVIK AMIT
18 granted patents·35 pending applications·252 citations·filing 2004–2024
94Inventor score
Top patents by PatentIndex Score
53 records- 0197US7569662B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancerCOMPUGEN LTD·Filed 2005·Granted Aug 4, 2009·73 cites·3 claims
- 0296US7667001B1Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of lung cancerCOMPUGEN LTD·Filed 2007·Granted Feb 23, 2010·75 cites·9 claims
- 0393US7332569B2Brain natriuretic peptide spliced variantCOMPUGEN LTD·Filed 2005·Granted Feb 19, 2008·26 cites·1 claims
- 0492US9409987B2Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancerTOPORIK AMIR·Filed 2012·Granted Aug 9, 2016·22 cites·12 claims
- 0590US7345142B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac diseaseCOMPUGEN LTD·Filed 2005·Granted Mar 18, 2008·16 cites·8 claims
- 0687US7842459B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosisCOMPUGEN LTD·Filed 2005·Granted Nov 30, 2010·7 cites·5 claims
- 0786US7714100B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of cardiac diseaseCOMPUGEN LTD·Filed 2007·Granted May 11, 2010·3 cites·6 claims
- 0885US8415455B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2008·Granted Apr 9, 2013·9 cites·14 claims
- 0984US9107862B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Aug 18, 2015·5 cites·9 claims
- 1082US7553948B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancerCOMPUGEN LTD·Filed 2007·Granted Jun 30, 2009·6 cites·5 claims
- 1181US9375466B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Jun 28, 2016·3 cites·4 claims
- 1281US2024025973A1Pvrig polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 1378US10550173B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2016·Granted Feb 4, 2020·2 cites·10 claims
- 1475US2022048972A1Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancerCOMPUGEN LTD·Filed 2021·Application pending·0 cites
- 1574US9555087B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2014·Granted Jan 31, 2017·1 cites·27 claims
- 1673US10098934B2Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2013·Granted Oct 16, 2018·1 cites·9 claims
- 1772US2024287174A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 1870US11795209B2PVRIG polypeptides and methods of treatmentCOMPUGEN LTD·Filed 2020·Granted Oct 24, 2023·0 cites·15 claims
- 1970US7906635B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancerCOMPUGEN LTD·Filed 2009·Granted Mar 15, 2011·2 cites·8 claims
- 2070US2010248270A1Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Cardiac DiseaseCOMPUGEN LTD·Filed 2009·Application pending·0 cites
- 2169US2011311450A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsLEVINE ZURIT·Filed 2009·Application pending·0 cites
- 2268US7528243B2Nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancerCOMPUGEN LTD·Filed 2007·Granted May 5, 2009·1 cites·5 claims
- 2365US2024425607A1Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancerCOMPUGEN LTD·Filed 2024·Application pending·0 cites
- 2463US2018298109A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2018·Application pending·0 cites
- 2563US2025297018A1Il-18bp antagonist antibodies and their use in monotherapy and combination therapy in the treatment of cancerCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 2660US2024103010A1Pvrl2 and/or pvrig as biomarkers for treatmentCOMPUGEN LTD·Filed 2023·Application pending·0 cites
- 2759US2018194829A1Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancerCOMPUGEN LTD·Filed 2017·Application pending·0 cites
- 2858US2010068736A1Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Lung CancerCOMPUGEN LTD·Filed 2009·Application pending·0 cites
- 2958US2017037141A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 3058US2009286957A1Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancerCOMPUGEN LTD·Filed 2009·Application pending·0 cites
- 3156US2011091454A1Methods and systems for annotating biomolecular sequencesDIBER ALEX·Filed 2010·Application pending·0 cites
- 3256US2016068606A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2015·Application pending·0 cites
- 3355US9347952B2Soluble VEGFR-1 variants for diagnosis of preeclampsiaCOMPUGEN LTD·Filed 2015·Granted May 24, 2016·0 cites·2 claims
- 3455US2017107284A1Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 3555US2006068405A1Methods and systems for annotating biomolecular sequencesDIBER ALEX·Filed 2005·Application pending·0 cites
- 3654US2016216281A1Soluble vegfr-1 variants and assays and methods of use thereof for diagnosisCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 3754US2016347816A1Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancerCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 3854US2023400467A1Pvrl2 and/or pvrig as biomarkers for treatmentCOMPUGEN LTD·Filed 2021·Application pending·0 cites
- 3953US2009075257A1Novel nucleic acid sequences and methods of use thereof for diagnosisCOMPUGEN LTD·Filed 2007·Application pending·0 cites
- 4052US2016177395A1Biomarkers for the prediction of renal injuryCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 4149US2004265799A1Human-virus homologous sequences and uses thereofCOMPUGEN LTD·Filed 2004·Application pending·0 cites
- 4249US2006147946A1Novel calcium channel variants and methods of use thereofAKIVA PINCHAS·Filed 2005·Application pending·0 cites
- 4348US2018305451A1Hide1 compositions and methodsCOMPUGEN LTD·Filed 2016·Application pending·0 cites
- 4448US2008182299A1Novel brain natriuretic peptide variants and methods of use thereofCOMPUGENT LTD·Filed 2007·Application pending·0 cites
- 4548US2006183131A1Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of breast cancerTOPORIK AMIR·Filed 2005·Application pending·0 cites
- 4648US2009215046A1Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancerCOMPUGEN LTD·Filed 2007·Application pending·0 cites
- 4747US2009176217A1Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosisSELLA-TAVOR OSNAT·Filed 2006·Application pending·0 cites
- 4844US2011003708A1Biomarkers for the prediction of renal injuryCOMPUGEN LTD·Filed 2010·Application pending·0 cites
- 4943US2006014166A1Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of endometriosisCOHEN YOSSI·Filed 2005·Application pending·0 cites
- 5043US2006040278A1Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis of ovarian cancerCOJOCARU GAD S·Filed 2005·Application pending·0 cites
Showing the top 50 of 53 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →